January 07, 2014
BTG to present at the 32nd Annual J.P. Morgan Healthcare Conference

London, UK, 07 January 2014

BTG plc (LSE: BTG), the specialist healthcare company today announces that Louise Makin, CEO will be presenting an overview of the company at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, 15 January at 9am local (PST) time.

A PDF of the presentation will be available on BTG’s website at the same time.

For further information please contact:

BTG
Andy Burrows, Director of Investor Relations
+44 (0)20 7575 1741; Mobile: +44 (0)7990 530605

Rolf Soderstrom, Chief Financial Officer
+44 (0)20 7575 0000

FTI Consulting
Ben Atwell
+44 (0)20 7831 3113

About BTG
BTG is an international specialist healthcare company that is developing and commercializing products targeting acute care, cancer and vascular diseases. The company has diversified revenues from sales of its own marketed products and from royalties on partnered products, and is seeking to acquire new programmes and products to develop and market to specialist physicians.